Atara Biotherapeutics Inc (ATRA)
0.67
+0.02
(+3.03%)
USD |
NASDAQ |
May 03, 16:00
0.69
+0.02
(+2.99%)
After-Hours: 07:48
Atara Biotherapeutics Market Cap: 80.68M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 80.68M |
| May 02, 2024 | 78.31M |
| May 01, 2024 | 82.42M |
| April 30, 2024 | 83.09M |
| April 29, 2024 | 86.00M |
| April 26, 2024 | 82.36M |
| April 25, 2024 | 83.53M |
| April 24, 2024 | 85.31M |
| April 23, 2024 | 85.77M |
| April 22, 2024 | 83.24M |
| April 19, 2024 | 78.90M |
| April 18, 2024 | 82.56M |
| April 17, 2024 | 85.33M |
| April 16, 2024 | 81.36M |
| April 15, 2024 | 81.00M |
| April 12, 2024 | 84.51M |
| April 11, 2024 | 85.08M |
| April 10, 2024 | 85.66M |
| April 09, 2024 | 89.44M |
| April 08, 2024 | 90.24M |
| April 05, 2024 | 92.40M |
| April 04, 2024 | 92.97M |
| April 03, 2024 | 85.94M |
| April 02, 2024 | 86.86M |
| April 01, 2024 | 86.54M |
| Date | Value |
|---|---|
| March 28, 2024 | 82.84M |
| March 27, 2024 | 83.55M |
| March 26, 2024 | 78.90M |
| March 25, 2024 | 79.96M |
| March 22, 2024 | 83.24M |
| March 21, 2024 | 79.85M |
| March 20, 2024 | 85.94M |
| March 19, 2024 | 72.68M |
| March 18, 2024 | 63.40M |
| March 15, 2024 | 66.08M |
| March 14, 2024 | 67.06M |
| March 13, 2024 | 71.00M |
| March 12, 2024 | 74.51M |
| March 11, 2024 | 77.23M |
| March 08, 2024 | 81.06M |
| March 07, 2024 | 74.12M |
| March 06, 2024 | 74.29M |
| March 05, 2024 | 73.61M |
| March 04, 2024 | 79.90M |
| March 01, 2024 | 82.04M |
| February 29, 2024 | 82.82M |
| February 28, 2024 | 80.95M |
| February 27, 2024 | 84.63M |
| February 26, 2024 | 75.68M |
| February 23, 2024 | 78.38M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
23.42M
Minimum
Nov 10 2023
2.043B
Maximum
Dec 07 2020
752.64M
Average
740.78M
Median
Dec 05 2019
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 2.856M |
| Palatin Technologies Inc | 34.05M |
| iBio Inc | 6.934M |
| Theriva Biologics Inc | 6.911M |
| Oragenics Inc | 4.794M |
Market Cap Related Metrics
| PS Ratio | 8.277 |
| PEG Ratio | -0.0146 |
| Price | 0.67 |
| Earnings Yield | -391.0% |
| PEGY Ratio | -0.0146 |